Skip Navigation


Human Molecular Genetics Advance Access originally published online on February 5, 2004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
13/suppl_1/R149    most recent
ddh069v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Shoulders, C.C.
Right arrow Articles by Naoumova, R.P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shoulders, C.C.
Right arrow Articles by Naoumova, R.P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2004, Vol. 13, Review Issue 1 R149-R160
DOI: 10.1093/hmg/ddh069

Genetics of familial combined hyperlipidemia and risk of coronary heart disease

C.C. Shoulders*, E.L. Jones and R.P. Naoumova

MRC Clinical Sciences Centre, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK

Coronary heart disease is the leading cause of death in developed countries. This alarming statistic is partly attributable to lifestyle, and partly due to the genetic factors that make humans highly susceptible to atherosclerotic vascular disease. The principal metabolic causes of atherosclerosis include hyperlipidemia, hypertension, obesity, insulin resistance and diabetes mellitus. Here we discuss the aetiology of familial combined hyperlipidemia (FCHL), a highly atherogenic disorder affecting 1–2% of the Western world. Genome-wide linkage studies indicate that more than three genes contribute to the pernicious lipid profile of FCHL, and that these genes reside within the 1q21–23, 11p14.1–q12.1 and 16q22–24.1 chromosomal regions. Other loci include 1p31, 6q16.1–16.3 and 8p23.3–22, but the linkage data for these are not yet persuasive. Combined linkage and association analyses provide compelling evidence for the involvement of two distinct alleles at the APOA1/C3/A4/A5 gene cluster in the transmission of FCHL. An important lesson arising from the study of a complex genetic disorder, such as FCHL, that lacks a consensus on diagnostic criteria, is that an understanding of complex genetic disorders can derive from comparative analyses of genome-wide linkage data generated from conditions that share phenotypic overlap. The identification of potential genetic overlap between FCHL and the Metabolic Syndrome, which is estimated to affect 47 million Americans, promises to deliver new targets for reducing the risk of important conditions such as cardiovascular disease and stroke.

* To whom correspondence should be addressed. Tel: +44 2083838308; Fax: +44 2083832028; Email: carol.shoulders{at}csc.mrc.ac.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Clin. Pathol.Home page
G Ferns, V Keti, and B Griffin
Investigation and management of hypertriglyceridaemia
J. Clin. Pathol., November 1, 2008; 61(11): 1174 - 1183.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
H. Grallert, E.-M. Sedlmeier, C. Huth, M. Kolz, I. M. Heid, C. Meisinger, C. Herder, K. Strassburger, A. Gehringer, M. Haak, et al.
APOA5 variants and metabolic syndrome in Caucasians
J. Lipid Res., December 1, 2007; 48(12): 2614 - 2621.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
R. P. Naoumova, H. Kindler, L. Leccisotti, M. Mongillo, M. T. Khan, C. Neuwirth, M. Seed, P. Holvoet, J. Betteridge, and P. G. Camici
Pioglitazone Improves Myocardial Blood Flow and Glucose Utilization in Nondiabetic Patients With Combined Hyperlipidemia: A Randomized, Double-Blind, Placebo-Controlled Study
J. Am. Coll. Cardiol., November 5, 2007; (2007) j.jacc.2007.07.070v1.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Plata, C. R. Sussman, A. Sindic, J. O. Liang, D. B. Mount, Z. M. Josephs, M.-H. Chang, and M. F. Romero
Zebrafish Slc5a12 Encodes an Electroneutral Sodium Monocarboxylate Transporter (SMCTn): A COMPARISON WITH THE ELECTROGENIC SMCT (SMCTe/Slc5a8)
J. Biol. Chem., April 20, 2007; 282(16): 11996 - 12009.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. C.G.J. Brouwers, N. Kono, M. M.J. van Greevenbroek, C. J.H. van der Kallen, A. J. Lusis, T. W.A. de Bruin, and R. M. Cantor
Longitudinal Differences in Familial Combined Hyperlipidemia Quantitative Trait Loci.
Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): e118 - e119.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.